Orphazyme: Short reflection on the transition of CEO

Research Note

2019-07-15

13:21

Earlier today, Orphazyme announced that they have appointed Kim Stratton as the new CEO for the company, succeeding Anders Hinsby. The transition will formally happen on October 1, 2019. In this note, we give our short view to today’s news.

AH

Anders Hedlund

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.